Laurine Levillayer

Laurine Levillayer is a Researcher at Institut Pasteur, focusing on immunology and virology projects. Her work spans T-cell immunity, flavivirus infections, and vaccine development for pathogens like SARS-CoV-2, Zika virus, and Dengue virus.

Her research includes:

• Developing DNA vaccines targeting immunodominant T-cell epitopes for flaviviruses.
• Elucidating SKAP2 protein architecture and its role in SRC kinase interactions and cell signaling.
• Investigating B-cell dynamics in tocilizumab-treated convalescent patients during the COVID-19 pandemic.

Key trends in her publications include molecular mechanisms of immune crosstalk, protein interactome analyses, and transgenic mouse models for viral immunity. Her work emphasizes cellular and molecular aspects of host-pathogen interactions and vaccine efficacy without neutralizing antibodies.